What are the recommended treatment options for a patient with focal axillary hyperhidrosis who experienced irritation with Drysol (aluminum chloride hexahydrate)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 4, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment Options for Focal Axillary Hyperhidrosis After Drysol Irritation

For patients who experienced irritation with aluminum chloride hexahydrate (Drysol), the best alternative is a formulation combining 15% aluminum chloride hexahydrate with 2% salicylic acid in a gel base, which offers excellent efficacy with minimal irritation. 1

Understanding the Irritation Problem

The FDA label for Drysol explicitly states to "discontinue use if irritation appears," confirming that irritation is a recognized limitation of this first-line therapy 2. While aluminum chloride remains the gold standard initial treatment for axillary hyperhidrosis 3, 4, irritant dermatitis can be so severe that many patients must discontinue therapy despite clinical efficacy 1.

Primary Alternative: Modified Aluminum Chloride Formulation

  • The combination of 15% aluminum chloride hexahydrate with 2% salicylic acid in a gel base has been specifically developed to address the irritation problem 1
  • Clinical observations from hyperhidrosis practices demonstrate that this formulation provides decreased irritation and increased efficacy compared to standard aluminum chloride preparations 1
  • Seven documented cases showed patients with a history of severe irritation from standard aluminum chloride maintained excellent results with this formulation without significant irritation 1

Second-Line Treatment: Botulinum Toxin Type A

If topical therapy continues to be intolerable or ineffective, botulinum toxin type A (BTX-A) injections are the recommended second-line treatment for axillary hyperhidrosis 4, 5.

  • BTX-A is FDA-approved specifically for primary focal axillary hyperhidrosis unresponsive to topical therapy 6
  • At 4 weeks post-treatment, 92% of patients achieved treatment response (≥2 grade improvement on the Hyperhidrosis Disease Severity Scale) compared to only 33% with 20% aluminum chloride 6
  • BTX-A provides greater patient satisfaction than aluminum chloride and is considered first- or second-line treatment for axillary hyperhidrosis 3, 4
  • Injections are administered at the dermal-subcutaneous junction and serve as a safe and effective treatment option 5

Alternative Aluminum Salt: Aluminum Sesquichlorohydrate

  • 20% aluminum sesquichlorohydrate (AS) demonstrates similar efficacy to 20% aluminum chloride but with a potentially better safety profile 7
  • In a randomized controlled trial, both AS and AC showed positive results with no significant difference in efficacy, but AS had fewer adverse effects (only 5% reported itching with AC, none with AS) 7
  • Application protocol: nightly for 2 weeks, then three times weekly for 4 weeks, with therapeutic effects persisting at least 2 weeks after cessation 7

Third-Line Treatment: Oral Glycopyrrolate

For patients who fail topical therapies, oral glycopyrrolate is recommended as third-line treatment 4, 8.

  • Start with glycopyrrolate 1 mg twice daily, increasing to 2 mg twice daily if inadequate response 4, 8
  • When added to topical aluminum chloride, cumulative response increases from 15.3% (topical alone) to 45.8% (with 1 mg BD) and 55.9% (with 2 mg BD) 8
  • Glycopyrrolate is preferred over clonidine 0.1 mg twice daily due to better safety profile and reasonable efficacy 4
  • Oral anticholinergics are useful adjuncts in severe cases when other treatments fail 3

Additional Treatment Options

Iontophoresis

  • While primarily recommended for palmoplantar hyperhidrosis, iontophoresis can be considered though it has high initial cost and inconvenience 4

Newer Device-Based Therapies

  • Local microwave therapy is a newer treatment option specifically for axillary hyperhidrosis 3
  • Energy-delivering devices including lasers, ultrasound technology, microwave thermolysis, and fractional microneedle radiofrequency may reduce focal sweating 5

Surgical Options (Last Resort)

  • Local surgery is considered fourth-line treatment for axillary hyperhidrosis 4
  • Techniques include excision, curettage, liposuction, or combinations thereof 5
  • Endoscopic thoracic sympathectomy (ETS) is fifth-line treatment and should only be considered in severe cases unresponsive to all other therapies 3, 4
  • Surgery is reserved as treatment of last resort after accepting compensatory hyperhidrosis as a potential complication 5

Treatment Algorithm for This Patient

  1. First attempt: 15% aluminum chloride hexahydrate with 2% salicylic acid gel (addresses the irritation issue directly) 1
  2. If still intolerable: Consider 20% aluminum sesquichlorohydrate as alternative aluminum salt 7
  3. If topical therapy fails: Botulinum toxin type A injections 3, 4, 6
  4. If injections inadequate: Add oral glycopyrrolate 1-2 mg twice daily 4, 8
  5. Refractory cases: Consider microwave therapy or other energy-based devices 3, 5
  6. Last resort: Local surgical excision or sympathectomy 4, 5

Important Caveats

  • Patient education is an important component of management 9
  • Lifestyle and behavioral recommendations should accompany all treatments 5
  • The Hyperhidrosis Disease Severity Scale should be used to grade tolerability and guide treatment decisions 3, 6
  • Most treatments except physical destruction of sweat glands are not permanent and require ongoing therapy 9

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.